Universität zu Köln

Journal Article

Cornely, Oliver A., Maher, Rochelle M., Marty, Francisco M. ORCID: 0000-0002-3708-8734, Lee, Misun, Vehreschild, J. Janne and Vehreschild, Maria J. G. T. (2016). The VITAL study: case control studies are hypothesis-generating Reply. Lancet Infect. Dis., 16 (8). S. 886 - 889. OXFORD: ELSEVIER SCI LTD. ISSN 1474-4457

Maertens, Johan A., Raad, Issam I., Marr, Kieren A., Patterson, Thomas F., Kontoyiannis, Dimitrios P., Cornely, Oliver A., Bow, Eric J., Rahav, Galia, Neofytos, Dionysios ORCID: 0000-0001-6970-2869, Aoun, Mickael, Baddley, John W., Giladi, Michael, Heinz, Werner J., Herbrecht, Raoul ORCID: 0000-0002-9381-4876, Hope, William ORCID: 0000-0001-6187-878X, Karthaus, Meinolf, Lee, Dong-Gun ORCID: 0000-0003-4655-0641, Lortholary, Olivier, Morrison, Vicki A., Oren, Ilana, Selleslag, Dominik, Shoham, Shmuel, Thompson, George R., III, Lee, Misun, Maher, Rochelle M., Schmitt-Hoffmann, Anne-Hortense, Zeiher, Bernhardt and Ullmann, Andrew J. (2016). Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. Lancet, 387 (10020). S. 760 - 770. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

Marty, Francisco M. ORCID: 0000-0002-3708-8734, Ostrosky-Zeichner, Luis, Cornely, Oliver A., Mullane, Kathleen M., Perfect, John R., Thompson, George R., III, Alangaden, George J., Brown, Janice M., Fredricks, David N., Heinz, Werner J., Herbrecht, Raoul ORCID: 0000-0002-9381-4876, Klimko, Nikolai, Klyasova, Galina, Maertens, Johan A., Melinkeri, Sameer R., Oren, Ilana, Pappas, Peter G., Racil, Zdenek, Rahav, Galia, Santos, Rodrigo, Schwartz, Stefan ORCID: 0000-0001-8833-5793, Vehreschild, J. Janne, Young, Jo-Anne H., Chetchotisakd, Ploenchan, Jaruratanasirikul, Sutep, Kanj, Souha S., Engelhardt, Marc, Kaufh, Achim, Ito, Masanori, Lee, Misun, Sasse, Carolyn, Maher, Rochelle M., Zeiher, Bernhardt and Vehreschild, Maria J. G. T. (2016). Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect. Dis., 16 (7). S. 828 - 838. OXFORD: ELSEVIER SCI LTD. ISSN 1474-4457

Thompson, George R., III, Rendon, Adrian ORCID: 0000-0001-8973-4024, dos Santos, Rodrigo Ribeiro, Queiroz-Telles, Flavio, Ostrosky-Zeichner, Luis, Azie, Nkechi, Maher, Rochelle, Lee, Misun, Kovanda, Laura, Engelhardt, Marc, Vazquez, Jose A., Cornely, Oliver A. and Perfect, John R. (2016). Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses. Clin. Infect. Dis., 63 (3). S. 356 - 363. CARY: OXFORD UNIV PRESS INC. ISSN 1537-6591

Vehreschild, Maria J. G. T., Vehreschild, J. Janne, Marty, Francisco M., Perfect, John R., Ostrosky-Zeichner, Luis, Rahav, Galia, Zeiher, Bernhardt, Lee, Misun, Maher, Rochelle, Lovell, Clint, Engelhardt, Marc and Cornely, Oliver A. (2014). Primary Treatment of Invasive Mucormycosis (IM) with Isavuconazole (VITAL Study) or Amphotericin Formulations (FungiScope (TM)): Case Matched Analysis. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020